These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 27514960)

  • 1. The antibiotics of choice for the treatment of melioidosis in Indian set up.
    Shaw T; Tellapragada C; Eshwara VK; Bhat HV; Mukhopadhyay C
    Indian J Med Microbiol; 2016; 34(3):353-4. PubMed ID: 27514960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current antimicrobial susceptibility of first-episode melioidosis Burkholderia pseudomallei isolates from the Northern Territory, Australia.
    Crowe A; McMahon N; Currie BJ; Baird RW
    Int J Antimicrob Agents; 2014 Aug; 44(2):160-2. PubMed ID: 24924662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiological cut-off value of clinical isolates of Burkholderia pseudomallei from Northern Queensland to meropenem, ceftazidime, trimethoprim/sulfamethoxazole and doxycycline by the microbroth dilution method.
    Maloney S; Engler C; Norton R
    J Glob Antimicrob Resist; 2017 Sep; 10():291-294. PubMed ID: 28729203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic susceptibility of Burkholderia pseudomallei from tropical northern Australia and implications for therapy of melioidosis.
    Jenney AW; Lum G; Fisher DA; Currie BJ
    Int J Antimicrob Agents; 2001 Feb; 17(2):109-13. PubMed ID: 11165114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial susceptibility patterns of Burkholderia pseudomallei among melioidosis cases in Kedah, Malaysia.
    Hassan MR; Vijayalakshmi N; Pani SP; Peng NP; Mehenderkar R; Voralu K; Michael E
    Southeast Asian J Trop Med Public Health; 2014 May; 45(3):680-8. PubMed ID: 24974653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Burkholderia pseudomallei: in vitro susceptibility to some new and old antimicrobials.
    Karunakaran R; Puthucheary SD
    Scand J Infect Dis; 2007; 39(10):858-61. PubMed ID: 17852912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial susceptibility pattern of clinical isolates of Burkholderia pseudomallei in Bangladesh.
    Dutta S; Haq S; Hasan MR; Haq JA
    BMC Res Notes; 2017 Jul; 10(1):299. PubMed ID: 28728591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial susceptibility of Burkholderia pseudomallei isolates in Northern Vietnam.
    Nhung PH; Van VH; Anh NQ; Phuong DM
    J Glob Antimicrob Resist; 2019 Sep; 18():34-36. PubMed ID: 30685463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Farnesol increases the susceptibility of Burkholderia pseudomallei biofilm to antimicrobials used to treat melioidosis.
    Castelo-Branco DS; Riello GB; Vasconcelos DC; Guedes GM; Serpa R; Bandeira TJ; Monteiro AJ; Cordeiro RA; Rocha MF; Sidrim JJ; Brilhante RS
    J Appl Microbiol; 2016 Mar; 120(3):600-6. PubMed ID: 26669506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and Characterization of Burkholderia pseudomallei from Localized Pyogenic Infections in Eastern India: A Clinico-Microbiological Study.
    Purushotham P; Mohanty S; Chappity P; Mishra TS; Mahapatra A
    Am J Trop Med Hyg; 2021 Feb; 104(4):1252-1259. PubMed ID: 33534740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Susceptibility of Clinical Isolates of
    Sengyee S; Saiprom N; Paksanont S; Limmathurotsakul D; Wuthiekanun V; Chantratita N
    Am J Trop Med Hyg; 2017 Jul; 97(1):62-67. PubMed ID: 28719324
    [No Abstract]   [Full Text] [Related]  

  • 12. Cases of melioidosis in a university teaching hospital in Malaysia.
    Raja NS
    J Microbiol Immunol Infect; 2008 Apr; 41(2):174-9. PubMed ID: 18473106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of tigecycline in the treatment of acute Burkholderia pseudomallei infection in a murine model.
    Feterl M; Govan B; Engler C; Norton R; Ketheesan N
    Int J Antimicrob Agents; 2006 Nov; 28(5):460-4. PubMed ID: 17046208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative in vitro susceptibility of Burkholderia pseudomallei to doripenem, ertapenem, tigecycline and moxifloxacin.
    Harris P; Engler C; Norton R
    Int J Antimicrob Agents; 2011 Jun; 37(6):547-9. PubMed ID: 21481571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trimethoprim/sulfamethoxazole resistance in clinical isolates of Burkholderia pseudomallei from Thailand.
    Saiprom N; Amornchai P; Wuthiekanun V; Day NP; Limmathurotsakul D; Peacock SJ; Chantratita N
    Int J Antimicrob Agents; 2015 May; 45(5):557-9. PubMed ID: 25758020
    [No Abstract]   [Full Text] [Related]  

  • 16. Antibiotic susceptibility of 50 clinical isolates of Burkholderia pseudomallei from Singapore.
    Sivalingam SP; Sim SH; Aw LT; Ooi EE
    J Antimicrob Chemother; 2006 Nov; 58(5):1102-3. PubMed ID: 16951412
    [No Abstract]   [Full Text] [Related]  

  • 17. Antibiotic susceptibility of 65 isolates of Burkholderia pseudomallei and Burkholderia mallei to 35 antimicrobial agents.
    Thibault FM; Hernandez E; Vidal DR; Girardet M; Cavallo JD
    J Antimicrob Chemother; 2004 Dec; 54(6):1134-8. PubMed ID: 15509614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of bla(PenA) and bla(OXA) in Burkholderia pseudomallei Isolated from Patients at Sappasitthiprasong Hospital and Their Susceptibility to Ceftazidime and Carbapenems.
    Panya M; Thirat S; Wanram S; Panomket P; Nilsakul J
    J Med Assoc Thai; 2016 Jan; 99 Suppl 1():S12-6. PubMed ID: 26817233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of Ceftolozane-Tazobactam against
    Slack A; Parsonson F; Cronin K; Engler C; Norton R
    Am J Trop Med Hyg; 2018 Aug; 99(2):281-282. PubMed ID: 29943711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Raising the Stakes: Loss of Efflux Pump Regulation Decreases Meropenem Susceptibility in Burkholderia pseudomallei.
    Sarovich DS; Webb JR; Pitman MC; Viberg LT; Mayo M; Baird RW; Robson JM; Currie BJ; Price EP
    Clin Infect Dis; 2018 Jul; 67(2):243-250. PubMed ID: 29394337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.